SusitnAKAlaska Public Notices, Explained
Active Public meeting or hearing Public Notices

Drug Utilization Review Committee

Department of Health · Notice #225596

What is this notice about?

The Alaska Department of Health's Drug Utilization Review Committee will hold a public meeting by teleconference only on Friday, November 20, 2026, at 1:00 p.m. Members of the public, including health care professionals, may send written material about agenda items by November 18, 2026. Drug manufacturers have an earlier deadline of November 6, 2026.

Why was this notice issued?

The Division of Health Care Services is sponsoring a scheduled meeting of the Drug Utilization Review Committee and is giving public notice of it.

What action is being taken?

Holding a Drug Utilization Review Committee meeting by teleconference and accepting written material related to the agenda items from drug manufacturers and the public.

Who is involved: Alaska Department of Health, Division of Health Care Services; Drug Utilization Review Committee; pharmaceutical manufacturers; health care professionals and members of the public

How can the public respond?

Respond by Wed, Nov 18, 2026 10 days from today.

“Public submissions should be received no later than November 18, 2026 to allow inclusion in the meeting. Pharmaceutical manufacturer Clinical Submissions will be accepted until November 6, 2026 at 4:00pm AK local time.”

Ways to respond

  • Email doh.hcs.pharmacy.info@alaska.gov
  • Mail 4601 Business Park Blvd, Bldg K, Anchorage, AK 99503
  • Online form (pharmaceutical manufacturers only) Clinical Submission form: https://health.alaska.gov/en/division-of-health-care-services/medicaid-pharmacy-and-therapeutics/

What to include

Submissions must relate to the meeting agenda items. A conflict of interest form must accompany any public submission: https://health.alaska.gov/dhcs/Documents/pharmacy/forms/Alaska-Medicaid-Clinical-Coverage-Review-Request-Disclosure-Form.pdf. Pharmaceutical manufacturers must use the Clinical Submission form and submit by November 6, 2026 at 4:00pm AK local time. Agendas are posted at https://health.alaska.gov/dhcs/Pages/pdl/drugutilizb_pdl.aspx.

Contact

Matthew Parrott
Alaska Department of Health, Division of Health Care Services
doh.hcs.pharmacy.info@alaska.gov
907.334.2425
4601 Business Park Blvd, Bldg K, Anchorage, AK 99503

Will there be public meetings?

  • Drug Utilization Review Committee meeting: Fri, Nov 20, 2026, 1:00 p.m.
    Teleconference only
    Register at https://events.teams.microsoft.com/event/8143b26e-826a-4ad3-9471-a63706855cc9@34c95ba7-5ec6-4527-bc5e-b33b58104992 (a confirmation email will include joining information), or dial toll free 1-844-730-9010, Webinar ID: 366 494 735#

Key dates

  • Nov 6, 2026: Deadline for pharmaceutical manufacturer Clinical Submissions (4:00pm AK local time)
  • Nov 18, 2026: Public submissions should be received by this date to be included in the meeting
  • Nov 18, 2026: Deadline to request disability accommodations from Matthew Parrott (2:00 p.m.)
  • Nov 20, 2026: Drug Utilization Review Committee meeting at 1:00 p.m. by teleconference

Original notice text
Notice of Public Meeting State of Alaska Department of Health Division of Health Care Services The Division will be sponsoring the following meeting to address the Drug Utilization Review. Please note, this meeting will be available via teleconference only. Please register for the meeting by using the link below: https://events.teams.microsoft.com/event/8143b26e-826a-4ad3-9471-a63706855cc9@34c95ba7-5ec6-4527-bc5e-b33b58104992 After registering, you will receive a confirmation email containing information about joining the webinar. The Drug Utilization Review Committee will meet Friday, November 20, 2026 at 1:00 p.m. Agendas are posted on the Health Care Services Drug Utilization website https://health.alaska.gov/dhcs/Pages/pdl/drugutilizb_pdl.aspx. If you would like to join via teleconference, please dial 1-844-730-9010. Webinar ID: 366 494 735# Any pharmaceutical manufacturer may submit unsolicited material related to the agenda items by utilizing the Clinical Submission form. Clinical Submissions will be accepted until November 6, 2026 at 4:00pm AK local time. Forms may be found at: https://health.alaska.gov/en/division-of-health-care-services/medicaid-pharmacy-and-therapeutics/ Any member of the public, including health care professionals, may submit unsolicited material related to the agenda items by sending an email to doh.hcs.pharmacy.info@alaska.gov or via mail to 4601 Business Park Blvd, Bldg K, Anchorage, AK 99503. A conflict of interest form must accompany any submission and can be found at: https://health.alaska.gov/dhcs/Documents/pharmacy/forms/Alaska-Medicaid-Clinical-Coverage-Review-Request-Disclosure-Form.pdf. Submissions should be received no later than November 18, 2026 to allow inclusion in the meeting. If you cannot join the webinar and would like to join via teleconference, please dial toll free 1-844-730-9010 Webinar ID: 366 494 735#. Individuals with disabilities who need special accommodations in order to participate should contact Matthew Parrott at 907.334.2425 no later than 2:00 p.m., Wednesday, November 18, 2026.

This summary was written by an AI model (Claude) from the official notice text. This is general information, not legal advice. Always confirm deadlines and instructions in the official notice. Legal disclaimer.